# Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

> **NCT07473700** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Tectonic Operating Company, Inc.** · enrollment: 25 (estimated)

## Conditions studied

- Hypertension, Pulmonary
- Lung Diseases, Interstitial

## Interventions

- **DRUG:** TX000045

## Key facts

- **NCT ID:** NCT07473700
- **Lead sponsor:** Tectonic Operating Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-30
- **Primary completion:** 2027-11-21
- **Final completion:** 2027-12-11
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07473700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07473700, "Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07473700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*